Deacetylation mimetic mutation of mitochondrial SOD2 attenuates ANG II-induced hypertension by protecting against oxidative stress and inflammation
Anna Dikalova, Mingfang Ao, Liliya Tkachuk, Sergey Dikalov
Abstract
Essential hypertension is associated with hyperacetylation of key mitochondrial antioxidant SOD2; however, the pathophysiological role of SOD2 acetylation has not been defined. Our animal study of angiotensin II hypertension model shows that deacetylation mimetic SOD2-K68R mutation prevents pathogenic increase in vascular mitochondrial superoxide, abrogates vascular oxidative stress, preserves endothelial nitric oxide, protects endothelial-dependent vasorelaxation, and attenuates hypertension. These data support the important role of SOD2-K68 acetylation in vascular oxidative stress and the pathogenesis of hypertension.
Topics & Concepts
SOD2Oxidative stressAngiotensin IISuperoxide dismutaseSuperoxideEndocrinologyInternal medicineChemistryReactive oxygen speciesEndothelial dysfunctionPharmacologyMitochondrial ROSMedicineBiochemistryBlood pressureEnzymeEicosanoids and Hypertension PharmacologyNitric Oxide and Endothelin EffectsHormonal Regulation and Hypertension